CSPM EDP Sciences logo
Access to submission and peer review system
Search
Menu
All issues Volume 6 (2025) Vis Cancer Med, 6 (2025) 7 References
Open Access
Issue
Vis Cancer Med
Volume 6, 2025
Article Number 7
Number of page(s) 5
DOI https://doi.org/10.1051/vcm/2025006
Published online 03 May 2025
  1. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. [CrossRef] [PubMed] [Google Scholar]
  2. Najafov A, Chen H, Yuan J. Necroptosis and cancer. Trends Cancer. 2017;3(4):294–301. [CrossRef] [PubMed] [Google Scholar]
  3. Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–296. [CrossRef] [PubMed] [Google Scholar]
  4. Xia X, Wang X, Cheng Z, et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis. 2019;10(9):650. [CrossRef] [PubMed] [Google Scholar]
  5. Mesner PJ, Budihardjo II, Kaufmann SH. Chemotherapy-induced apoptosis. Adv Pharmacol. 1997;41:461–499. [CrossRef] [PubMed] [Google Scholar]
  6. Wang RA. Life history tradeoffs of pathogens and the treatment principle of antibiogenesis. Genes Dis. 2017;4(3):154–158. [CrossRef] [PubMed] [Google Scholar]
  7. Wang RA, Zheng PJ, Liu Y, et al. Life history tradeoffs in humans: increased life expectancy with sperm count reduction. Front Biosci (Landmark Ed). 2019;24(4):712–722. [CrossRef] [PubMed] [Google Scholar]
  8. Russell RC, Guan KL. The multifaceted role of autophagy in cancer. EMBO J. 2022;41(13):e110031. [CrossRef] [PubMed] [Google Scholar]
  9. Wu Y, Wang A, Feng G, et al. Autophagy modulation in cancer therapy: Challenges coexist with opportunities. Eur J Med Chem. 2024;276:116688. [CrossRef] [PubMed] [Google Scholar]
  10. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402(6):672–676. [CrossRef] [PubMed] [Google Scholar]
  11. Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science. 1984;224(4656):1403–1406. [CrossRef] [PubMed] [Google Scholar]
  12. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 1992;80(4):879–886. [CrossRef] [PubMed] [Google Scholar]
  13. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. [CrossRef] [PubMed] [Google Scholar]
  14. Wang RA, Li ZS, Yan QG, et al. Resistance to apoptosis should not be taken as a hallmark of cancer. Chin J Cancer. 2014;33(2):47–50. [CrossRef] [PubMed] [Google Scholar]
  15. Wang RA, Li QL, Li ZS, et al. Apoptosis drives cancer cells proliferate and metastasize. J Cell Mol Med. 2013;17(1):205–211. [CrossRef] [PubMed] [Google Scholar]
  16. Krajewski S, Krajewska M, Turner BC, et al. Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer. 1999;6(1)29–40. [CrossRef] [PubMed] [Google Scholar]
  17. Lipponen P. Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer. 1999;6(1):13–16. [CrossRef] [PubMed] [Google Scholar]
  18. Gregory CD, Ford CA, Voss JJ. Microenvironmental effects of cell death in malignant disease. Adv Exp Med Biol. 2016;930:51–88. [CrossRef] [PubMed] [Google Scholar]
  19. Labi V, Erlacher M. How cell death shapes cancer. Cell Death Dis. 2015;6(3):e1675. [CrossRef] [PubMed] [Google Scholar]
  20. Ford CA, Petrova S, Pound JD, et al. Oncogenic properties of apoptotic tumor cells in aggressive B cell lymphoma. Curr Biol. 2015;25(5):577–588. [CrossRef] [PubMed] [Google Scholar]
  21. Yin C, Knudson CM, Korsmeyer SJ, et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 1997;385(6617):637–640. [CrossRef] [PubMed] [Google Scholar]
  22. Knudson CM, Johnson GM, Lin Y, et al. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res. 2001;61(2):659–665. [PubMed] [Google Scholar]
  23. Chen L, Park SM, Tumanov AV, et al. CD95 promotes tumour growth. Nature. 2010;465(7297):492–496. [CrossRef] [PubMed] [Google Scholar]
  24. Su F, Theodosis CN, Schneider RJ. Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol. 2001;75(1):215–225. [CrossRef] [PubMed] [Google Scholar]
  25. Motavaf M, Safari S, Saffari JM, et al. Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol. 2013;57(4):389–396. [CrossRef] [PubMed] [Google Scholar]
  26. Pietenpol JA, Papadopoulos N, Markowitz S, et al. Paradoxical inhibition of solid tumor cell growth by Bcl2. Cancer Res. 1994;54(14):3714–3717. [PubMed] [Google Scholar]
  27. de La Coste A, Mignon A, Fabre M, et al. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. Cancer Res. 1999;59(19):5017–5022. [PubMed] [Google Scholar]
  28. Murphy KL, Kittrell FS, Gay JP, et al. Bcl-2 expression delays mammary tumor development in dimethylbenz(a)anthracene-treated transgenic mice. Oncogene. 1999;18(47):6597–6604. [CrossRef] [PubMed] [Google Scholar]
  29. Wang WQ, Liu L, Sun HC, et al. Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization. J Hematol Oncol. 2012;5:69. [CrossRef] [PubMed] [Google Scholar]
  30. Paez-Ribes M, Allen E, Hudock J, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009;15(3):220–231. [CrossRef] [PubMed] [Google Scholar]
  31. Ebos JM, Lee CR, Cruz-Munoz W, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009;15(3):232–239. [CrossRef] [PubMed] [Google Scholar]
  32. Zhu XD, Sun HC, Xu HX, et al. Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models. Angiogenesis. 2013;16(4):809–820. [CrossRef] [PubMed] [Google Scholar]
  33. Yan DH, Abramian A, Li Z, et al. P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochem Biophys Res Commun. 2003;303(1):219–222. [CrossRef] [PubMed] [Google Scholar]
  34. Choubey D. P202: an interferon-inducible negative regulator of cell growth. J Biol Regul Homeost Agents. 2000;14(3):187–192. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.